Direkt zum Inhalt
Merck
  • Inhibitory effects of pain relief drugs on neurological enzymes: implications on their potential neurotoxicity to aquatic animals.

Inhibitory effects of pain relief drugs on neurological enzymes: implications on their potential neurotoxicity to aquatic animals.

Environmental toxicology and pharmacology (2015-03-25)
Jui-Pin Wu, Mei-Hui Li
ZUSAMMENFASSUNG

Pain relief medications commonly occur in the aquatic environment at measurable levels. While the neurotoxicity of pain relievers to higher vertebrates is currently known, little is known about their effects on aquatic animals. This study investigated the neurotoxicity of pain relievers to aquatic animals. We used three neurological enzymes, cholinesterase (ChE), adenosine triphosphatase (ATPase), and monoamine oxidase (MAO), from a freshwater planarian (Dugesia japonica) and green neon shrimp (Neocaridina denticulata) as biomarkers to examine the effects of pain relievers on in vitro activity. The activity of MAO and ChE, but not ATPase, was significantly inhibited by acetaminophen, but not by other pain relievers examined. It was likely that the inhibitory effects of acetaminophen on shrimp neurological enzymes were more severe than on the planarian. These findings suggest that acetaminophen is potentially neurotoxic to aquatic animals, at least in terms of neurotransmission disturbance.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Acetylsalicylsäure, ≥99.0%
Sigma-Aldrich
4-Acetamidophenol, BioXtra, ≥99.0%
Sigma-Aldrich
Diclofenac Natriumsalz
Sigma-Aldrich
Aspirin, meets USP testing specifications
Sigma-Aldrich
4-Acetamidophenol, meets USP testing specifications, 98.0-102.0%, powder
Sigma-Aldrich
4-Acetamidophenol, analytical standard
Sigma-Aldrich
Acetylsalicylsäure, analytical standard
Sigma-Aldrich
Mefenaminsäure
Supelco
Acetaminophen solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®